sb 203580 and alitretinoin
sb 203580 has been researched along with alitretinoin in 2 studies
Compound Research Comparison
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (alitretinoin) | Trials (alitretinoin) | Recent Studies (post-2010) (alitretinoin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 854 | 47 | 269 |
Protein Interaction Comparison
| Protein | Taxonomy | sb 203580 (IC50) | alitretinoin (IC50) |
|---|---|---|---|
| retinoic acid receptor alpha isoform 1 | Homo sapiens (human) | 0.0084 | |
| retinoic acid receptor RXR-alpha isoform a | Homo sapiens (human) | 0.0189 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 0.007 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.007 | |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.031 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.017 | |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | 0.0305 | |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | 0.082 | |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | 0.012 | |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.004 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bradley, KA; Damoiseaux, R; Gillespie, EJ; Huang, J; Manchester, M; Rogers, J; Sanchez, AM; Saxe, JP; Thomas, D | 1 |
| Bartlett, JB; Colston, KW; Dalgleish, AG; Man, HW; Mouratidis, PX; Muller, GW; Stirling, D | 1 |
Other Studies
2 other study(ies) available for sb 203580 and alitretinoin
| Article | Year |
|---|---|
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
Topics: Amiodarone; Animals; Anthrax; Antigens, Bacterial; Bacterial Toxins; Bepridil; Cell Line; Cell Survival; Chloroquine; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Macrophages, Peritoneal; Male; Mice; Molecular Structure; Rats; Rats, Inbred F344; Time Factors | 2007 |
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cells.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Tretinoin | 2009 |